Company
Headquarters: Kirrawee, NSW, Australia
CEO: Mr. Chin Leng Khoo
A$101.2 Million
AUD as of Jan. 1, 2024
US$69.0 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Vita Life Sciences Limited, a pharmaceutical and healthcare company, develops and distributes over the counter (OTC) medicines, complementary and alternative medicines, dietary supplements, and health foods. The company offers products for nervous system, children's health, nutritional oils, immunity, hair, skin, nails, liver and digestion, nutritional's, weight management, cardiovascular health, pain, inflammation, pregnancy and breastfeeding, men and women health, antioxidant, and bones and joints. The company markets its products through pharmacies and health food stores under the Herbs of Gold, VitaHealth, VitaScience, and VitaLife brands. It operates in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, China, and internationally. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Vita Life Sciences Limited has the following listings and related stock indices.
Stock: ASX: VLS wb_incandescent